{"id":252051,"date":"2018-08-10T02:07:01","date_gmt":"2018-08-10T02:07:01","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=252051"},"modified":"2018-08-10T02:07:01","modified_gmt":"2018-08-10T02:07:01","slug":"hiv-drugs-market-2018-global-share-trends-challenges-and-opportunities-research-report-forecast-to-2025","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/hiv-drugs-market-2018-global-share-trends-challenges-and-opportunities-research-report-forecast-to-2025_252051.html","title":{"rendered":"HIV Drugs Market 2018 Global Share, Trends, Challenges and Opportunities Research Report Forecast to 2025"},"content":{"rendered":"<div style=\" width:250px; padding:8px 10px 10px 10px; float:right;\"><a href=\"http:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2018\/08\/1533879990.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"image\" src=\"http:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2018\/08\/1533879990.jpeg\" alt=\"\" width=\"225\" height=\"\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\" style=\" font-weight:bold; font-style:italic;\">\n<div>&#8220;\\&#8221;HIV Drugs Market\\&#8221;&#8221;<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">Wiseguyreports.Com Added New Market Research Report On -\u201cGlobal HIV Drugs Market 2018 Top Manufacturers, Production , Growth and Future Demand Forecast to 2025  \u201d.<\/div>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Global HIV Drugs Market<\/strong><\/p>\n<p><strong>WiseGuyRerports.com Presents &ldquo;Global HIV Drugs Market Research Report 2018&rdquo; New Document to its Studies Database. The Report Contain 99 Pages With Detailed Analysis.<\/strong><\/p>\n<p><strong>Description<\/strong><\/p>\n<p>This report studies the global HIV Drugs market status and forecast, categorizes the global HIV Drugs market size (value &amp; volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East &amp; Africa.<\/p>\n<p>HIV is a type of retrovirus that causes serious complications in humans. It generally spreads via the blood, semen, vaginal fluid, pre-ejaculate, or breast milk. The global market for HIV drugs is envisaged to surpass USD 19,000 million by 2019 owing to the recent rise in HIV patient population.&nbsp;<\/p>\n<p>One of the primary factors catalyzing the growth of the global HIV drugs market is increase in the prevalence of HIV and its diagnosis. Apart from this, the market is also influenced by a rise in the number of government initiatives for spreading the awareness amongst people regarding causes, symptoms and treatments. Moreover, the introduction of generic drugs, which are cost-effective and chemically identical to branded drugs, act as another factor that is contributing towards the demand for HIV drugs.&nbsp;<\/p>\n<p><strong>&nbsp;<\/strong><\/p>\n<p><strong>Get sample Report @ <\/strong><a rel=\"nofollow\" href=\"https:\/\/www.wiseguyreports.com\/sample-request\/3328895-global-hiv-drugs-market-research-report-2018\"><strong>https:\/\/www.wiseguyreports.com\/sample-request\/3328895-global-hiv-drugs-market-research-report-2018<\/strong><\/a><\/p>\n<p><strong>&nbsp;<\/strong><\/p>\n<p>The <strong>major manufacturers<\/strong> covered in this report&nbsp;<br \/>Bristol-Myers Squibb&nbsp;<br \/>Gilead Sciences&nbsp;<br \/>GlaxoSmithKline&nbsp;<br \/>Johnson &amp; Johnson&nbsp;<br \/>Merck<\/p>\n<p><strong>Geographically<\/strong>, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering&nbsp;<br \/>North America&nbsp;<br \/>Europe&nbsp;<br \/>China&nbsp;<br \/>Japan&nbsp;<br \/>Southeast Asia&nbsp;<br \/>India<\/p>\n<p><strong>We can also provide the customized separate regional or country-level reports<\/strong>, for the following regions:&nbsp;<br \/>North America&nbsp;<br \/>United States&nbsp;<br \/>Canada&nbsp;<br \/>Mexico&nbsp;<br \/>Asia-Pacific&nbsp;<br \/>China&nbsp;<br \/>India&nbsp;<br \/>Japan&nbsp;<br \/>South Korea&nbsp;<br \/>Australia&nbsp;<br \/>Indonesia&nbsp;<br \/>Singapore&nbsp;<br \/>Rest of Asia-Pacific&nbsp;<br \/>Europe&nbsp;<br \/>Germany&nbsp;<br \/>France&nbsp;<br \/>UK&nbsp;<br \/>Italy&nbsp;<br \/>Spain&nbsp;<br \/>Russia&nbsp;<br \/>Rest of Europe&nbsp;<br \/>Central &amp; South America&nbsp;<br \/>Brazil&nbsp;<br \/>Argentina&nbsp;<br \/>Rest of South America&nbsp;<br \/>Middle East &amp; Africa&nbsp;<br \/>Saudi Arabia&nbsp;<br \/>Turkey&nbsp;<br \/>Rest of Middle East &amp; Africa<\/p>\n<p><strong>On the basis of produ<\/strong>ct, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into&nbsp;<br \/>Multi-Class Combination Products&nbsp;<br \/>Nucleoside Reverse Transcriptase Inhibitors&nbsp;<br \/>Non-Nucleoside Reverse Transcriptase Inhibitors&nbsp;<br \/>Protease Inhibitors&nbsp;<br \/>Fusion Inhibitors&nbsp;<br \/>Entry Inhibitors &#8211; CCR5 Co-Receptor Antagonist&nbsp;<br \/>HIV Integrase Strand Transfer Inhibitors&nbsp;<\/p>\n<p><strong>On the basis of the end users\/applications<\/strong>, this report focuses on the status and outlook for major applications\/end users, consumption (sales), market share and growth rate for each application, including&nbsp;<br \/>Hospital Pharmacies&nbsp;<br \/>Retail Pharmacies&nbsp;<br \/>Online Pharmacies&nbsp;<br \/>Others<\/p>\n<p><strong>Key Stakeholders&nbsp;<br \/><\/strong>HIV Drugs Manufacturers&nbsp;<br \/>HIV Drugs Distributors\/Traders\/Wholesalers&nbsp;<br \/>HIV Drugs Subcomponent Manufacturers&nbsp;<br \/>Industry Association&nbsp;<br \/>Downstream Vendors<\/p>\n<p><strong>&nbsp;<\/strong><\/p>\n<p><strong>Complete Report Details <\/strong><strong>@ <\/strong><strong><a rel=\"nofollow\" href=\"https:\/\/www.wiseguyreports.com\/reports\/3328895-global-hiv-drugs-market-research-report-2018\">https:\/\/www.wiseguyreports.com\/reports\/3328895-global-hiv-drugs-market-research-report-2018<\/a><\/strong><\/p>\n<p><strong>&nbsp;<\/strong><\/p>\n<p><strong>Table of Contents -Major Key Points <\/strong><\/p>\n<p><strong>Global HIV Drugs Market Research Report 2018&nbsp;<br \/>1 HIV Drugs Market Overview&nbsp;<br \/><\/strong>1.1 Product Overview and Scope of HIV Drugs&nbsp;<br \/>1.2 HIV Drugs Segment by Type (Product Category)&nbsp;<br \/>1.2.1 Global HIV Drugs Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)&nbsp;<br \/>1.2.2 Global HIV Drugs Production Market Share by Type (Product Category) in 2017&nbsp;<br \/>1.2.3 Multi-Class Combination Products&nbsp;<br \/>1.2.4 Nucleoside Reverse Transcriptase Inhibitors&nbsp;<br \/>1.2.5 Non-Nucleoside Reverse Transcriptase Inhibitors&nbsp;<br \/>1.2.6 Protease Inhibitors&nbsp;<br \/>1.2.7 Fusion Inhibitors&nbsp;<br \/>1.2.8 Entry Inhibitors &#8211; CCR5 Co-Receptor Antagonist&nbsp;<br \/>1.2.9 HIV Integrase Strand Transfer Inhibitors&nbsp;<br \/>1.3 Global HIV Drugs Segment by Application&nbsp;<br \/>1.3.1 HIV Drugs Consumption (Sales) Comparison by Application (2013-2025)&nbsp;<br \/>1.3.2 Hospital Pharmacies&nbsp;<br \/>1.3.3 Retail Pharmacies&nbsp;<br \/>1.3.4 Online Pharmacies&nbsp;<br \/>1.3.5 Others&nbsp;<br \/>1.4 Global HIV Drugs Market by Region (2013-2025)&nbsp;<br \/>1.4.1 Global HIV Drugs Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)&nbsp;<br \/>1.4.2 North America Status and Prospect (2013-2025)&nbsp;<br \/>1.4.3 Europe Status and Prospect (2013-2025)&nbsp;<br \/>1.4.4 China Status and Prospect (2013-2025)&nbsp;<br \/>1.4.5 Japan Status and Prospect (2013-2025)&nbsp;<br \/>1.4.6 Southeast Asia Status and Prospect (2013-2025)&nbsp;<br \/>1.4.7 India Status and Prospect (2013-2025)&nbsp;<br \/>1.5 Global Market Size (Value) of HIV Drugs (2013-2025)&nbsp;<br \/>1.5.1 Global HIV Drugs Revenue Status and Outlook (2013-2025)&nbsp;<br \/>1.5.2 Global HIV Drugs Capacity, Production Status and Outlook (2013-2025)<\/p>\n<p><strong>&hellip;&hellip;&hellip;&hellip;&hellip;..<\/strong><\/p>\n<p><strong>7 Global HIV Drugs Manufacturers Profiles\/Analysis&nbsp;<br \/><\/strong>7.1 Bristol-Myers Squibb&nbsp;<br \/>7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors&nbsp;<br \/>7.1.2 HIV Drugs Product Category, Application and Specification&nbsp;<br \/>7.1.2.1 Product A&nbsp;<br \/>7.1.2.2 Product B&nbsp;<br \/>7.1.3 Bristol-Myers Squibb HIV Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)&nbsp;<br \/>7.1.4 Main Business\/Business Overview&nbsp;<br \/>7.2 Gilead Sciences&nbsp;<br \/>7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors&nbsp;<br \/>7.2.2 HIV Drugs Product Category, Application and Specification&nbsp;<br \/>7.2.2.1 Product A&nbsp;<br \/>7.2.2.2 Product B&nbsp;<br \/>7.2.3 Gilead Sciences HIV Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)&nbsp;<br \/>7.2.4 Main Business\/Business Overview&nbsp;<br \/>7.3 GlaxoSmithKline&nbsp;<br \/>7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors&nbsp;<br \/>7.3.2 HIV Drugs Product Category, Application and Specification&nbsp;<br \/>7.3.2.1 Product A&nbsp;<br \/>7.3.2.2 Product B&nbsp;<br \/>7.3.3 GlaxoSmithKline HIV Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)&nbsp;<br \/>7.3.4 Main Business\/Business Overview&nbsp;<br \/>7.4 Johnson &amp; Johnson&nbsp;<br \/>7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors&nbsp;<br \/>7.4.2 HIV Drugs Product Category, Application and Specification&nbsp;<br \/>7.4.2.1 Product A&nbsp;<br \/>7.4.2.2 Product B&nbsp;<br \/>7.4.3 Johnson &amp; Johnson HIV Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)&nbsp;<br \/>7.4.4 Main Business\/Business Overview&nbsp;<br \/>7.5 Merck&nbsp;<br \/>7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors&nbsp;<br \/>7.5.2 HIV Drugs Product Category, Application and Specification&nbsp;<br \/>7.5.2.1 Product A&nbsp;<br \/>7.5.2.2 Product B&nbsp;<br \/>7.5.3 Merck HIV Drugs Capacity, Production, Revenue, Price and Gross Margin (2015-2018)&nbsp;<br \/>7.5.4 Main Business\/Business Overview<\/p>\n<p><strong>&nbsp;<\/strong><strong>&hellip;&hellip;..CONTINUED<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p><strong>&nbsp;<\/strong><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> Wiseguyreports.com<br \/><strong>Contact Person:<\/strong> Norah Trent<br \/><strong>Email:<\/strong> <a href='http:\/\/www.universalpressrelease.com\/?pr=hiv-drugs-market-2018-global-share-trends-challenges-and-opportunities-research-report-forecast-to-2025&#038;type=pra'>Send Email<\/a><br \/><strong>Phone:<\/strong> +1 646 845 9349, +44 208 133 9349<br \/><strong>City:<\/strong> Pune<br \/><strong>State:<\/strong> Maharashtra<br \/><strong>Country:<\/strong> India<br \/><strong>Website:<\/strong> <a href=\"http:\/\/www.wiseguyreports.com\" target=\"_blank\" rel=\"nofollow\">www.wiseguyreports.com<\/a><\/p>\n<p><object type=\"text\/html\" data=\"http:\/\/www.wiseguyreports.com\" style=\"width:605px; height:400px;\"><\/object><\/p>\n<p><img decoding=\"async\" src=\"http:\/\/www.abnewswire.com\/press_stat.php?pr=hiv-drugs-market-2018-global-share-trends-challenges-and-opportunities-research-report-forecast-to-2025\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8220;\\&#8221;HIV Drugs Market\\&#8221;&#8221; Wiseguyreports.Com Added New Market Research Report On -\u201cGlobal HIV Drugs Market 2018 Top Manufacturers, Production , Growth and Future Demand Forecast to 2025 \u201d. &nbsp; &nbsp; Global HIV Drugs Market WiseGuyRerports.com Presents &ldquo;Global HIV Drugs Market Research &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/hiv-drugs-market-2018-global-share-trends-challenges-and-opportunities-research-report-forecast-to-2025_252051.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-252051","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/252051","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=252051"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/252051\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=252051"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=252051"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=252051"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}